Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.03B | 1.02B | 972.26M | 937.88M | 888.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.03B | 1.02B | 972.26M | 937.88M | 888.65M |
| Cost of Revenue | 713.58M | 704.13M | 673.45M | 650.30M | 617.01M |
| Gross Profit | 315.61M | 311.03M | 298.82M | 287.58M | 271.64M |
| SG&A Expenses | 264.86M | 261.73M | 250.43M | 243.34M | 226.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -237.60K | -1.18M | -116.80K | -117.90K | 1.62M |
| Total Operating Expenses | 978.20M | 964.68M | 923.76M | 893.53M | 844.76M |
| Operating Income | 50.99M | 50.48M | 48.50M | 44.35M | 43.89M |
| Income Before Tax | 24.41M | 24.47M | 24.56M | 19.45M | 20.62M |
| Income Tax Expenses | 10.93M | 9.75M | 8.72M | 6.81M | 7.40M |
| Earnings from Continuing Operations | 13.48 | 14.73 | 15.84 | 12.64 | 13.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.48M | 14.73M | 15.84M | 12.64M | 13.21M |
| EBIT | 50.99M | 50.48M | 48.50M | 44.35M | 43.89M |
| EBITDA | 109.77M | 106.64M | 103.71M | 106.62M | 101.11M |
| EPS Basic | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 |
| Normalized Basic EPS | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 |
| EPS Diluted | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 |
| Normalized Diluted EPS | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 |
| Average Basic Shares Outstanding | 1.64B | 1.64B | 1.64B | 1.64B | 1.64B |
| Average Diluted Shares Outstanding | 1.64B | 1.64B | 1.64B | 1.64B | 1.64B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
